Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OO...
A look at the updated Berkshire Hathaway portfolio after the second quarter, including a new stake in UnitedHealth.
Wells Fargo analyst Daniel Osley maintains Lamar Advertising (NASDAQ:LAMR) with a Equal-Weight and lowers the price target f...
JP Morgan analyst David Karnovsky maintains Lamar Advertising (NASDAQ:LAMR) with a Neutral and lowers the price target from ...
Lamar Advertising (NASDAQ:LAMR) raises FY2025 GAAP EPS guidance from $6.01-$6.07 to $6.09-$6.11 vs $5.79 analyst estimate..
Lamar Advertising (NASDAQ:LAMR) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $0....
